The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis.
Rafael PaternostroKatharina LampichlerConstanze BardachUlrika AsenbaumClara LandlerDavid BauerMattias MandorferRemy SchwarzerMichael TraunerThomas ReibergerArnulf FerlitschPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Low muscle mass was highly prevalent in our cohort of patients with cirrhosis. Gender-specific TPMT, SMI and PSMI cut-offs for low muscle mass can help identify patients with an increased risk for mortality. Importantly, only TPMT emerged as an independent risk factor for mortality in patients with cirrhosis.